<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="77341">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02045745</url>
  </required_header>
  <id_info>
    <org_study_id>CSM/FAP/2012</org_study_id>
    <secondary_id>2013-000535-27</secondary_id>
    <nct_id>NCT02045745</nct_id>
  </id_info>
  <brief_title>CLINICAL TRIAL PHASE I / II, PROSPECTIVE, OPEN, NONRANDOMIZED, FOR TREATMENT OF POSTOPERATIVE AIR LEAK AFTER LUNG RESECTION IN HIGH RISK PATIENTS THROUGH THE ADMINISTRATION OF MESENCHYMAL AUTOLOGOUS CELLS.</brief_title>
  <acronym>CSM/FAP/2012</acronym>
  <official_title>CLINICAL TRIAL PHASE I / II, PROSPECTIVE, OPEN, NONRANDOMIZED, FOR TREATMENT OF POSTOPERATIVE AIR LEAK AFTER LUNG RESECTION IN HIGH RISK PATIENTS THROUGH THE ADMINISTRATION OF MESENCHYMAL AUTOLOGOUS CELLS.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Red de Terapia Celular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Castilla y León Hematology and hemotherapy Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Haematology Service,University Hospital of Salamanca, MªConsuelo del Cañizo Fernández-Roldán</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Spanish National Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Red de Terapia Celular</source>
  <oversight_info>
    <authority>Spain: Spanish Agency of Medicines</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to analyze the safety and feasibility of the implantation of
      autologous mesenchymal stem cells (MSCs) expanded &quot;in vitro&quot; and administered directly in
      the lung line of suture as a treatment for patients at risk of postoperative air leaks after
      lung resection.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Safety of the procedure</measure>
    <time_frame>During the procedure and postoperative period (48 hours)</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Security is measured in terms of: Adverse effects derived from the implantation of the CSM</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analyze the efficacy of the procedure</measure>
    <time_frame>Postoperative period (48 hours), 1 month, 3 months, 6, 12 and 24 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Clinical:
Duration of postoperative air leak
Amount of leakage and trends measured by digital memory device
Cardiorespiratory complications
Radiological:
Pneumothorax on chest radiograph.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Prolonged Postoperative Air Leaks in Risk Patients.</condition>
  <arm_group>
    <arm_group_label>Prolonged postoperative air leaks in risk patients.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implantation of autologous mesenchymal stem cells (CSM) expanded &quot;in vitro&quot; and administered directly into the lung suture line</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Implantation of autologous mesenchymal stem cells (CSM) expanded &quot;in vitro&quot; and administered directly into the lung suture line</intervention_name>
    <arm_group_label>Prolonged postoperative air leaks in risk patients.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 70 years

          -  Patients who will be subjected to programmed anatomic lung resection (pneumonectomy
             excluded)

          -  Patients class C or D on the risk scale of air leak Patients included in the study
             must meet all inclusion criteria.

        Exclusion Criteria:

        Patients with any of the following exclusion criteria may not be included in the clinical
        trial:

          -  Those considered by the investigator are not on a good position to tolerate the
             procedure

          -  Clinical criteria and anesthetics that contraindicate surgery

          -  Uncontrolled severe disease

          -  Pregnant women

          -  Patients infected with hepatitis B, hepatitis C, syphilis and HIV + virus

          -  People who are taking a drug under clinical investigation or participated in any
             study under clinical investigation (or an authorized product) within 30 days prior to
             randomization

          -  The absence of informed consent or revocation thereof
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marcelo F Jiménez López, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Clinical Hospital of Salamanca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gonzalo Varela Simó, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>University Clinical Hospital of Salamanca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nuria M Novoa Valentín, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>University Clinical Hospital of Salamanca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>José L Aranda Alcaide, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>University Clinical Hospital of Salamanca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Consuelo del Cañizo, Ph.D</last_name>
    <role>Study Director</role>
    <affiliation>University Clinical Hospital of Salamanca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fermín Sánchez-Guijo Martín, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>University Clinical Hospital of Salamanca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Olga López Villar, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>University Clinical Hospital of Salamanca</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eva M Villarón Ríos, Ph.D</last_name>
    <role>Study Chair</role>
    <affiliation>University Clinical Hospital of Salamanca</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fermín Sánchez-Guijo Martín, Ph.D</last_name>
    <phone>+34923294624</phone>
    <email>ferminsg@usal.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Clinical Hospital of Salamanca</name>
      <address>
        <city>Salamanca</city>
        <state>Salamanca/Castilla León</state>
        <zip>37007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fermín Sánchez-Guijo Martín, Ph.D</last_name>
      <phone>+34923294624</phone>
      <email>ferminsg@usal.es</email>
    </contact>
    <investigator>
      <last_name>Marcelo F Jiménez López, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gonzalo Varela Simó, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nuria M Novoa Valentín, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose L Aranda Alcaide, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Consuelo del Cañizo, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fermín Sánchez-Guijo Martín, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olga López Villar, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eva M Villarón Ríos, Ph.D</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 22, 2014</lastchanged_date>
  <firstreceived_date>January 22, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prolonged postoperative air leaks in risk patients.</keyword>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
